Genomic profiling of 766 cancer‐related genes in archived esophageal normal and carcinoma tissues

We employed the BeadArray™ technology to perform a genetic analysis in 33 formalin‐fixed, paraffin‐embedded (FFPE) human esophageal carcinomas, mostly squamous‐cell‐carcinoma (ESCC), and their adjacent normal tissues. A total of 1,432 single nucleotide polymorphisms (SNPs) derived from 766 cancer‐related genes were genotyped with partially degraded genomic DNAs isolated from these samples. This directly targeted genomic profiling identified not only previously reported somatic gene amplifications (e.g., CCND1) and deletions (e.g., CDKN2A and CDKN2B) but also novel genomic aberrations. Among these novel targets, the most frequently deleted genomic regions were chromosome 3p (including tumor suppressor genes FANCD2 and CTNNB1) and chromosome 5 (including tumor suppressor gene APC). The most frequently amplified genomic region was chromosome 3q (containing DVL3, MLF1, ABCC5, BCL6, AGTR1 and known oncogenes TNK2, TNFSF10, FGF12). The chromosome 3p deletion and 3q amplification occurred coincidently in nearly all of the affected cases, suggesting a molecular mechanism for the generation of somatic chromosomal aberrations. We also detected significant differences in germline allele frequency between the esophageal cohort of our study and normal control samples from the International HapMap Project for 10 genes (CSF1, KIAA1804, IL2, PMS2, IRF7, FLT3, NTRK2, MAP3K9, ERBB2 and PRKAR1A), suggesting that they might play roles in esophageal cancer susceptibility and/or development. Taken together, our results demonstrated the utility of the BeadArray technology for high‐throughput genetic analysis in FFPE tumor tissues and provided a detailed genetic profiling of cancer‐related genes in human esophageal cancer. © 2008 Wiley‐Liss, Inc.

[1]  A. Poole,et al.  A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. , 2005, Cellular signalling.

[2]  A. Knudson,et al.  Chasing the cancer demon. , 2000, Annual review of genetics.

[3]  Illinois.,et al.  Cancer Genetics , 1976, British Journal of Cancer.

[4]  D. Parkin,et al.  Time trends in cancer mortality in China: 1987–1999 , 2003, International journal of cancer.

[5]  Cisca Wijmenga,et al.  High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArrays. , 2007, Genome research.

[6]  C. Harris,et al.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Gurtan,et al.  Dedicated to the core: understanding the Fanconi anemia complex. , 2006, DNA repair.

[8]  M. Kelliher,et al.  Interferon Regulatory Factor 7 Is Activated by a Viral Oncoprotein through RIP-Dependent Ubiquitination , 2007, Molecular and Cellular Biology.

[9]  Hun-Woong Park,et al.  Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas. , 2007, Oncology reports.

[10]  T. Naoe,et al.  Oncogenic protein tyrosine kinases , 2004, Cellular and Molecular Life Sciences CMLS.

[11]  H. Fujii,et al.  Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma , 2005, British Journal of Cancer.

[12]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[13]  D Bentley,et al.  Highly parallel SNP genotyping. , 2003, Cold Spring Harbor symposia on quantitative biology.

[14]  Nan Hu,et al.  Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. , 2005, Cancer research.

[15]  E. Stanley,et al.  Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.

[16]  K. Gunderson,et al.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. , 2006, Genome research.

[17]  Y. Assaraf.  The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  Olivier Poch,et al.  Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis , 2004, Oncogene.

[19]  K. Sugimachi,et al.  A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  I. Weinstein,et al.  Amplification and expression of the human cyclin D gene in esophageal cancer. , 1992, Cancer research.

[21]  J. Bartek,et al.  Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. , 1995, Cancer research.

[22]  K. Gunderson,et al.  Illumina universal bead arrays. , 2006, Methods in enzymology.

[23]  L. Lovat,et al.  Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance , 2006, Clinical Cancer Research.

[24]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.

[25]  A. D’Andrea,et al.  Molecular pathogenesis of Fanconi anemia: recent progress. , 2006, Blood.

[26]  S. Powers,et al.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Buetow,et al.  Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array , 2006, BMC Genomics.

[28]  P. Sham,et al.  High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. , 2006, Cancer Research.

[29]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[30]  J. Gray,et al.  The genetics and genomics of cancer , 2003, Nature Genetics.

[31]  Nan Hu,et al.  High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high‐risk Chinese population , 2004, Genes, chromosomes & cancer.

[32]  H. Harada,et al.  Mismatch repair and microsatellite instability in esophageal cancer cells , 2001, International journal of cancer.

[33]  M. Moasser.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis , 2007, Oncogene.

[34]  G. Hannon,et al.  Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. , 1995, Human molecular genetics.

[35]  Ajay N. Jain,et al.  Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. , 2002, Cancer research.

[36]  Vitaly L. Galinsky,et al.  Automatic registration of microarray images. II. Hexagonal grid , 2003, Bioinform..

[37]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[38]  Cisca Wijmenga,et al.  Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. , 2005, Cancer research.

[39]  O. Albagli-Curiel.  Ambivalent role of BCL6 in cell survival and transformation , 2003, Oncogene.

[40]  A. Nakagawara,et al.  Trk receptor tyrosine kinases: a bridge between cancer and neural development. , 2001, Cancer letters.

[41]  J. Jiricny.  The multifaceted mismatch-repair system , 2006, Nature Reviews Molecular Cell Biology.

[42]  W. Tan,et al.  Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. , 2004, Journal of the National Cancer Institute.

[43]  J. Jen,et al.  Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma , 1999, Oncogene.

[44]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[45]  T. Aoki,et al.  Cell cycle-regulated factors in esophageal cancer. , 2002, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[46]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[47]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[48]  M. Lerman,et al.  Critical tumor‐suppressor gene regions on chromosome 3P in major human epithelial malignancies: Allelotyping and quantitative real‐time PCR , 2002, International journal of cancer.

[49]  G. Marsischky,et al.  Eukaryotic DNA mismatch repair. , 1999, Current opinion in genetics & development.